0001437749-19-011066.txt : 20190530 0001437749-19-011066.hdr.sgml : 20190530 20190530160314 ACCESSION NUMBER: 0001437749-19-011066 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190528 FILED AS OF DATE: 20190530 DATE AS OF CHANGE: 20190530 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEDOUX MARK A CENTRAL INDEX KEY: 0001115556 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15701 FILM NUMBER: 19866513 MAIL ADDRESS: STREET 1: 1185 LINDA VISTA DR CITY: SAN MARCOS STATE: CA ZIP: 92069 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NATURAL ALTERNATIVES INTERNATIONAL INC CENTRAL INDEX KEY: 0000787253 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 841007839 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 1535 FARADAY AVENUE CITY: CARLSBAD STATE: CA ZIP: 92008-7319 BUSINESS PHONE: 6197447340 MAIL ADDRESS: STREET 1: 1535 FARADAY AVENUE CITY: CARLSBAD STATE: CA ZIP: 92008-7319 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN ACQUISITIONS INC DATE OF NAME CHANGE: 19860929 4 1 rdgdoc.xml FORM 4 X0306 4 2019-05-28 0000787253 NATURAL ALTERNATIVES INTERNATIONAL INC NAII 0001115556 LEDOUX MARK A 1535 FARADAY AVENUE CARLSBAD CA 92008 1 1 1 CEO/Chairman Common Stock 2019-05-28 4 D 0 15000 12.65 D 66009 D Common Stock 2019-05-28 4 D 0 5000 12.65 D 530000 I By LeDoux Family Limited Partnership Common Stock 176500 I By Self as Trustee for the LeDoux Family Trust U/D/T December 21, 1992 Common Stock 69416 I By IRA Common Stock 7200 I By Self as Custodian for Marcelle Jeannette LeDoux Common Stock 800 I By Self as Custodian for Jean-Marc Emile LeDoux Common Stock 4000 I By Self as Custodian for Aimee LeDoux This transaction represents a sale to the Company of 15,000 shares by the Company's CEO, and the sale of 5,000 shares by the affiliated family limited partnership of the CEO, both pursuant to the Company's Stock Repurchase Plan. The Company paid the purchase price of $12.65 by prior agreement with the Sellers that the price would be $0.25 per share less than the last trade on the Nasdaq market on the trading day prior to the date of the transfer of shares from the reporting persons to the Company. The sole general partner of the Seller is the CEO of the Company, who also has a beneficial interest as a limited partner. /s/ Kenneth E Wolf on behalf of Mr. LeDoux pursuant to a Power of Attorney 2019-05-29